17th Mar 2015 08:27
LONDON (Alliance News) - Deltex Medical Group PLC shares rose early Tuesday after the company said a newly-published study validates the use of the pulse pressure waveform analysis algorithm used in Deltex's CardioQ-ODM+ monitoring system.
The company, which makes oesophageal Doppler monitoring technology, said the study found the algorithm was superior to eight other published algorithms. The algorithm is used in Deltex's CardioQ monitors.
"This is important high quality validation of our CardioQ-ODM+ that shows we are offering clinicians two best in class technologies in the same monitor. We expect shortly to announce progress with new parameters based around the unique combination of ODM an PPWA," said Deltex Chief Executive Ewan Phillips.
Deltex shares were up 6.2% to 6.9 pence on Tuesday morning, one of the best performers in the AIM All-Share index.
By Sam Unsted; [email protected]; @SamUAtAlliance
Copyright 2015 Alliance News Limited. All Rights Reserved.
Related Shares:
Deltex Medical